UK markets closed

Shattuck Labs, Inc. (STTK)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
35.43+0.90 (+2.61%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous close34.53
Open34.62
Bid35.36 x 800
Ask35.65 x 2200
Day's range33.63 - 35.90
52-week range17.51 - 35.91
Volume183,849
Avg. volume322,167
Market cap1.479B
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est35.00
  • Business Wire

    Shattuck Labs to Present at TIGIT Therapies Digital Summit 2020

    Shattuck Labs, Inc. ("Shattuck"), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today announced its presentation at the TIGIT Therapies Digital Summit 2020 being held virtually October 26 – 27, 2020.

  • Business Wire

    Shattuck Labs Announces Pricing of Upsized Initial Public Offering

    Shattuck Labs, Inc. ("Shattuck"), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of cancer and autoimmune disease, today announced the pricing of its upsized initial public offering of 11,882,352 shares of common stock at a public offering price of $17.00 per share. The gross proceeds to Shattuck from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Shattuck, are expected to be approximately $202 million. All of the shares are being offered by Shattuck. The shares are expected to begin trading on The Nasdaq Global Select Market on October 9, 2020 under the ticker symbol "STTK." In addition, Shattuck has granted the underwriters a 30-day option to purchase up to an additional 1,782,352 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The offering is expected to close on October 14, 2020 subject to the satisfaction of customary closing conditions.